Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The clinical promise of biomarkers of synapse damage or loss in Alzheimer’s disease
Martí Colom‐Cadena, Tara L. Spires‐Jones, Henrik Zetterberg, et al.
Alzheimer s Research & Therapy (2020) Vol. 12, Iss. 1
Open Access | Times Cited: 249

Showing 1-25 of 249 citing articles:

KOBAS-i: intelligent prioritization and exploratory visualization of biological functions for gene enrichment analysis
Dechao Bu, Haitao Luo, Peipei Huo, et al.
Nucleic Acids Research (2021) Vol. 49, Iss. W1, pp. W317-W325
Open Access | Times Cited: 1239
Amyloid β-based therapy for Alzheimer’s disease: challenges, successes and future
Yun Zhang, Huaqiu Chen, Ran Li, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 364
Synaptic degeneration in Alzheimer disease
Makis Tzioras, Robert I. McGeachan, Claire S. Durrant, et al.
Nature Reviews Neurology (2022) Vol. 19, Iss. 1, pp. 19-38
Closed Access | Times Cited: 250
Phosphorylated Tau in Alzheimer’s Disease and Other Tauopathies
Priyanka Rawat, Ujala Sehar, Jasbir Bisht, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12841-12841
Open Access | Times Cited: 192
Amyloid Beta in Aging and Alzheimer’s Disease
Ujala Sehar, Priyanka Rawat, Arubala P. Reddy, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12924-12924
Open Access | Times Cited: 179
The metal ion hypothesis of Alzheimer’s disease and the anti-neuroinflammatory effect of metal chelators
Lilin Chen, Yonggang Fan, Lingxiao Zhao, et al.
Bioorganic Chemistry (2022) Vol. 131, pp. 106301-106301
Closed Access | Times Cited: 112
SARS-CoV-2 Spike protein induces TLR4-mediated long-term cognitive dysfunction recapitulating post-COVID-19 syndrome in mice
Fabrícia Lima Fontes-Dantas, Gabriel Gripp Fernandes, Elisa Gouvea Gutman, et al.
Cell Reports (2023) Vol. 42, Iss. 3, pp. 112189-112189
Open Access | Times Cited: 109
Helicobacter pylori‐derived outer membrane vesicles contribute to Alzheimer's disease pathogenesis via C3‐C3aR signalling
Junhua Xie, Lien Cools, Griet Van Imschoot, et al.
Journal of Extracellular Vesicles (2023) Vol. 12, Iss. 2
Open Access | Times Cited: 78
Alzheimer’s disease as a synaptopathy: Evidence for dysfunction of synapses during disease progression
S. Meftah, Jian Gan
Frontiers in Synaptic Neuroscience (2023) Vol. 15
Open Access | Times Cited: 73
Alzheimer’s Disease: Novel Targets and Investigational Drugs for Disease Modification
Jeffrey L. Cummings, Amanda M. Leisgang Osse, Jefferson W. Kinney
Drugs (2023) Vol. 83, Iss. 15, pp. 1387-1408
Open Access | Times Cited: 65
Microglia‐synapse engulfment via PtdSer‐TREM2 ameliorates neuronal hyperactivity in Alzheimer's disease models
Javier Rueda‐Carrasco, Dimitra Sokolova, Sang‐Eun Lee, et al.
The EMBO Journal (2023) Vol. 42, Iss. 19
Open Access | Times Cited: 50
Moving beyond amyloid and tau to capture the biological heterogeneity of Alzheimer’s disease
Tracy L. Young‐Pearse, Hyo Lee, Yi‐Chen Hsieh, et al.
Trends in Neurosciences (2023) Vol. 46, Iss. 6, pp. 426-444
Open Access | Times Cited: 49
Tau Oligomer–Containing Synapse Elimination by Microglia and Astrocytes in Alzheimer Disease
Raquel N. Taddei, Romain Perbet, Anastasie Maté de Gérando, et al.
JAMA Neurology (2023) Vol. 80, Iss. 11, pp. 1209-1209
Open Access | Times Cited: 47
Elevated CSF GAP-43 is associated with accelerated tau accumulation and spread in Alzheimer’s disease
Nicolai Franzmeier, Amir Dehsarvi, Anna Steward, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 22
The Common Alzheimer's Disease Research Ontology (CADRO) for biomarker categorization
Amanda M. Leisgang Osse, Jefferson W. Kinney, Jeffrey L. Cummings
Alzheimer s & Dementia Translational Research & Clinical Interventions (2025) Vol. 11, Iss. 1
Open Access | Times Cited: 2
Fluid Biomarkers for Synaptic Dysfunction and Loss
Elena Camporesi, Johanna Nilsson, Ann Brinkmalm, et al.
Biomarker Insights (2020) Vol. 15, pp. 117727192095031-117727192095031
Open Access | Times Cited: 108
Systems-based proteomics to resolve the biology of Alzheimer’s disease beyond amyloid and tau
Sruti Rayaprolu, Lenora Higginbotham, Pritha Bagchi, et al.
Neuropsychopharmacology (2020) Vol. 46, Iss. 1, pp. 98-115
Open Access | Times Cited: 100
Recent update on the heterogeneity of the Alzheimer’s disease spectrum
K. A. Jellinger
Journal of Neural Transmission (2021) Vol. 129, Iss. 1, pp. 1-24
Closed Access | Times Cited: 86
Reversal of synapse loss in Alzheimer mouse models by targeting mGluR5 to prevent synaptic tagging by C1Q
Joshua Spurrier, LaShae Nicholson, Xiaotian T. Fang, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 647
Open Access | Times Cited: 69
New insights into the role and mechanisms of ginsenoside Rg1 in the management of Alzheimer’s disease
Jiaojiao Wu, Yang Yu, Yan Wan, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 152, pp. 113207-113207
Open Access | Times Cited: 68
Biomarkers for Alzheimer’s Disease in the Current State: A Narrative Review
Serafettin Gunes, Yumi Aizawa, Takuma Sugashi, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 4962-4962
Open Access | Times Cited: 60
Increased levels of the synaptic proteins PSD-95, SNAP-25, and neurogranin in the cerebrospinal fluid of patients with Alzheimer’s disease
Pia Kivisäkk, Becky C. Carlyle, Thadryan Sweeney, et al.
Alzheimer s Research & Therapy (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
Imaging Synaptic Density: The Next Holy Grail of Neuroscience?
Maria Elisa Serrano Navacerrada, Eugene Kim, Marija M. Petrinovic, et al.
Frontiers in Neuroscience (2022) Vol. 16
Open Access | Times Cited: 44
Integrative metabolomics science in Alzheimer’s disease: Relevance and future perspectives
Simone Lista, Raúl González‐Domínguez, Susana López‐Ortiz, et al.
Ageing Research Reviews (2023) Vol. 89, pp. 101987-101987
Closed Access | Times Cited: 34
Damaged mitochondria coincide with presynaptic vesicle loss and abnormalities in alzheimer’s disease brain
Wenzhang Wang, Fanpeng Zhao, Yubing Lu, et al.
Acta Neuropathologica Communications (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 27
Page 1 - Next Page

Scroll to top